“…Dispersions containing crystalline areas exhibit biphasic release profiles, with the amorphous areas dissolving quickly and the crystalline areas more slowly. For example, for a crystalline drug with a very poor aqueous solubility, the formation of an amorphous mixture with a water-soluble additive can provide an opportunity to enhance the dissolution and perhaps bioavailability [35].…”